HOWL Long Put Strategy
HOWL (Werewolf Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
HOWL (Werewolf Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $15.7M, a beta of 0.27 versus the broader market, a 52-week range of 0.313-2.38, average daily share volume of 548K, a public-listing history dating back to 2021, approximately 46 full-time employees. These structural characteristics shape how HOWL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.27 indicates HOWL has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on HOWL?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current HOWL snapshot
As of June 30, 2026, spot at $0.35, ATM IV 17.50%, IV rank 0.00%, expected move 5.02%. The long put on HOWL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long put structure on HOWL specifically: HOWL IV at 17.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a HOWL long put, with a market-implied 1-standard-deviation move of approximately 5.02% (roughly $0.02 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HOWL expiries trade a higher absolute premium for lower per-day decay. Position sizing on HOWL should anchor to the underlying notional of $0.35 per share and to the trader's directional view on HOWL stock.
HOWL long put setup
The HOWL long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HOWL near $0.35, the first option leg uses a $0.35 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HOWL chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HOWL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $0.35 | N/A |
HOWL long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
HOWL long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on HOWL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on HOWL
Long puts on HOWL hedge an existing long HOWL stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying HOWL exposure being hedged.
HOWL thesis for this long put
The market-implied 1-standard-deviation range for HOWL extends from approximately $0.33 on the downside to $0.37 on the upside. A HOWL long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long HOWL position with one put per 100 shares held. Current HOWL IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on HOWL at 17.50%. As a Healthcare name, HOWL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HOWL-specific events.
HOWL long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HOWL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HOWL alongside the broader basket even when HOWL-specific fundamentals are unchanged. Long-premium structures like a long put on HOWL are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current HOWL chain quotes before placing a trade.
Frequently asked questions
- What is a long put on HOWL?
- A long put on HOWL is the long put strategy applied to HOWL (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With HOWL stock trading near $0.35, the strikes shown on this page are snapped to the nearest listed HOWL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are HOWL long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the HOWL long put priced from the end-of-day chain at a 30-day expiry (ATM IV 17.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a HOWL long put?
- The breakeven for the HOWL long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HOWL market-implied 1-standard-deviation expected move is approximately 5.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on HOWL?
- Long puts on HOWL hedge an existing long HOWL stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying HOWL exposure being hedged.
- How does current HOWL implied volatility affect this long put?
- HOWL ATM IV is at 17.50% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.